Endo Pharmaceuticals Holdings (NASDAQ: ENDP) reported Q2 EPS of $1.42, $0.27 better than the analyst estimate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE